Abstract
Complex polysaccharides and lipopolysaccharides can activate the terminal components of complement by either the classical (antibody, C1, C4, and C2) or alternative complement pathways, but the relative importance of either pathway for terminal component consumption in normal serum is poorly understood. Since classical complement pathway function requires both calcium and magnesium ions, whereas the alternative pathway requires only magnesium ions, selective chelation of calcium ions in serum can be used to block the classical complement pathway while leaving the alternative pathway intact. In these studies, ethyleneglycol-bis-(beta-aminoethyl ether)N, N-tetraacetic acid, a potent chelator or calcium, was used to block the classical complement pathway in normal guinea pig serum. Consumption of the terminal complement components by endotoxin, inulin, and zymosan in such serum was strikingly depressed when compared to serum containing an intact classical complement pathway. These studies demonstrate that in normal serum, both the classical and alternative complement pathways participate in the consumption of the terminal complement components by complex polysaccharides and lipopolysaccharides.
MeSH Terms
Animals
Calcium/deficiency
Chelating Agents
Complement System Proteins/deficiency,metabolism
Endotoxins
Erythrocytes/immunology
Guinea Pigs/immunology
Hemolysis
Humans
Inulin
Lipopolysaccharides/pharmacology
Magnesium Deficiency
Polysaccharides, Bacterial
Protein Denaturation
Proteus vulgaris/immunology
Sheep/immunology
Snakes
Venoms
Zymosan
gamma-Globulins
Chemicals
Chelating Agents
Endotoxins
Lipopolysaccharides
Polysaccharides, Bacterial
Venoms
gamma-Globulins
Inulin
Complement System Proteins
Zymosan
Calcium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Snyderman R
Pike M C
References (25)
25 references, click to expand
-
The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
J Immunol. 1973 Nov;111(5):1389-400
PMID: 4795621
-
The complement system.
Sci Am. 1973 Nov;229(5):54-66
PMID: 4748119
-
Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia.
Int Arch Allergy Appl Immunol. 1967;32(1):64-90
PMID: 4864667
-
A specific inactivator of mammalian C'4 isolated from nurse shark (Ginglymostoma cirratum) serum.
J Exp Med. 1969 Aug 1;130(2):217-41
PMID: 4893886
-
Significance of complement to the mechanism of action of endotoxin.
Curr Top Microbiol Immunol. 1969;50:37-77
PMID: 4907133
-
Highlights of complement research during the past twenty-five years.
Immunochemistry. 1970 May;7(5):485-96
PMID: 4920409
-
Effect of C4 depletion on the utilization of the terminal components of guinea-pig complement by endotoxin.
Nat New Biol. 1971 Jun 2;231(22):152-4
PMID: 4997056
-
In vitro studies of complement function in sera of C4-deficient guinea pigs.
J Exp Med. 1971 Jul 1;134(1):176-87
PMID: 4997584
-
Production of chemotactic activity by guinea pig immunoglobulins following activation of the C3 complement shunt pathway.
J Immunol. 1972 May;108(5):1227-31
PMID: 5029138
-
Macrophage proteinase and inflammation: the production of chemotactic activity from the fifth complement by macrophage proteinase.
J Immunol. 1972 Oct;109(4):896-8
PMID: 5074336
-
Functional relationship of factor B in the properdin system to C3 proactivator of human serum.
J Immunol. 1971 Oct;107(4):1200-4
PMID: 5093780
-
Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.
J Exp Med. 1971 Nov 1;134(5):1131-43
PMID: 5112201
-
Dual pathways of complement interaction with guinea pig immunoglobulins.
J Immunol. 1971 Nov;107(5):1268-73
PMID: 5117668
-
Calcium requirements for complement dependent hemolytic reactions.
J Immunol. 1968 Oct;101(4):664-8
PMID: 5681648
-
A new method for the extraction of R lipopolysaccharides.
Eur J Biochem. 1969 Jun;9(2):245-9
PMID: 5804498
-
A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity.
Surv Ophthalmol. 1966 Aug;11(4):498-505
PMID: 5919620
-
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.
Science. 1954 Aug 20;120(3112):279-85
PMID: 13186838
-
Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes.
J Immunol. 1972 Aug;109(2):334-41
PMID: 4114826
-
The complement system of man. I.
N Engl J Med. 1972 Sep 7;287(10):489-95
PMID: 4114930
-
Effect of ageing of serum on consumption of antibody by beta-1C-globulin determinants; evidence for circulating breakdown products in glomerulonephritis.
Clin Exp Immunol. 1968 Jan;3(1):57-62
PMID: 4171046
-
Chemistry and reaction mechanisms of complement.
Adv Immunol. 1968;8:1-80
PMID: 4174135
-
Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.
J Exp Med. 1968 Nov 1;128(5):1049-57
PMID: 4176223
-
Activation of the classic and alternate complement pathways by endotoxin.
J Immunol. 1974 Feb;112(2):763-9
PMID: 4205207
-
C3 shunt activation in human serum chelated with EGTA.
J Immunol. 1972 Oct;109(4):807-9
PMID: 4627510
-
Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
J Immunol. 1974 Mar;112(3):1115-23
PMID: 4811964